Highest return-on-assets companies
Companies ranked by trailing return on assets (ROA) — how efficiently a business turns its asset base into profit. Delayed fundamentals from market data, shown with their as-of date.
Ranked by ROA: companies 3,001–3,025 of 3,067.
| # | Company | Sector | ROA | Net margin | Market cap |
|---|---|---|---|---|---|
| 3001 | Velo3D Inc (VELO) | Industrials | -78.1% | -155.2% | $179M |
| 3002 | BridgeBio Pharma (BBIO) | Health Care | -78.3% | -146.0% | $14.5B |
| 3003 | Vuzix Corporation (VUZI) | Information Technology | -80.5% | -513.9% | $160M |
| 3004 | Damora Therapeutics Inc (DMRA) | Health Care | -80.5% | n/a | $1.5B |
| 3005 | Lyell Immunopharma Inc (LYEL) | Health Care | -80.7% | -762355.6% | $365M |
| 3006 | Aeva Technologies Inc (AEVA) | Information Technology | -80.9% | -804.4% | $767M |
| 3007 | US Goldmining Inc (USGO) | Materials | -82.8% | n/a | $74M |
| 3008 | Nuvectis Pharma Inc (NVCT) | Health Care | -83.4% | n/a | $719M |
| 3009 | Richtech Robotics Inc Class B (RR) | Industrials | -83.7% | -972.7% | $200M |
| 3010 | Caribou Biosciences Inc (CRBU) | Health Care | -84.5% | -1327.4% | $48M |
| 3011 | Verastem Inc (VSTM) | Health Care | -85.0% | -677.6% | $1.1B |
| 3012 | Phathom Pharmaceuticals Inc (PHAT) | Health Care | -85.4% | -126.3% | $427M |
| 3013 | Editas Medicine Inc (EDIT) | Health Care | -85.8% | -395.0% | $395M |
| 3014 | AVITA Medical, Inc. (RCEL) | Health Care | -86.2% | -67.8% | $521M |
| 3015 | Pyxis Oncology, Inc. (PYXS) | Health Care | -87.0% | -574.5% | $199M |
| 3016 | MicroVision, Inc. (MVIS) | Information Technology | -92.1% | -7862.7% | $39M |
| 3017 | Scholar Rock Holding Corporation (SRRK) | Health Care | -93.5% | n/a | $5.7B |
| 3018 | Replimune Group Inc (REPL) | Health Care | -94.4% | n/a | $2.0B |
| 3019 | Lumentum (LITE) | Information Technology | -94.9% | -230.1% | $48.9B |
| 3020 | Inhibrx Biosciences Inc (INBX) | Health Care | -95.6% | -10773.5% | $1.2B |
| 3021 | Atomera Incorporated (ATOM) | Information Technology | -95.6% | -31036.9% | $118M |
| 3022 | Aspen Aerogels Inc (ASPN) | Materials | -95.8% | -143.7% | $408M |
| 3023 | OnKure Therapeutics Inc Class A (OKUR) | Health Care | -95.8% | n/a | $116M |
| 3024 | NET Power Inc Class A (NPWR) | Industrials | -96.5% | n/a | $182M |
| 3025 | Zenas BioPharma Inc (ZBIO) | Health Care | -98.5% | -3777.4% | $1.9B |
Find more highest return-on-assets companies like these →
Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Every figure is shown with its as-of date on the company page; a company with no data for this metric is excluded from the ranking, never estimated.
Last updated 2026-11-06 — rankings shift as the underlying data refreshes.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.